TipRanks
Go Ultimate55% OFF

Sienna Biopharmaceuticals (SNNAQ) Financial Statements

Sienna Biopharmaceuticals Financial Overview

Sienna Biopharmaceuticals's market cap is currently $31. The company's EPS TTM is $-2.00; its P/E ratio is 0.00; Sienna Biopharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ -157.00K$ -120.00K
Operating Income$ -76.50M$ -48.57M
EBITDA$ -76.34M$ -48.45M
Net Income$ -73.31M$ -50.55M
Balance Sheet
Cash & Short-Term Investments$ 48.53M$ 74.47M
Total Assets$ 107.31M$ 136.85M
Total Debt$ 30.13M$ 0.00
Net Debt$ -18.40M$ -74.47M
Total Liabilities$ 80.72M$ 45.65M
Stockholders' Equity$ 159.37M$ 85.90M
Cash Flow
Free Cash Flow$ -61.73M$ -41.36M
Operating Cash Flow$ -61.69M$ -41.08M
Investing Cash Flow$ -39.00K$ -266.00K
Financing Cash Flow$ 35.96M$ 106.78M

Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

-90M-60M-30M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018RevenueEarningsProfit Margin

Sienna Biopharmaceuticals Debt to Assets

050M100M150M20 %40 %60 %80 %LiabilitiesDebt to Assets20172018AssetsLiabilitiesDebt to Assets

Sienna Biopharmaceuticals Cash Flow

-100M-50M050M100M150M20172018OperatingInvestingFinancing

Sienna Biopharmaceuticals Forecast EPS vs Actual EPS

-1.1-1-0.9-0.8-0.7-0.6Q2 18Q3 18Q4 18Q1 19Q2 20EPS EstimateBeatMiss